SCHEMBL17437394

SCHEMBL17437394

Nc1ncnn1-c1nc2cncc(-c3ccc(Cl)cc3Cl)c2n1C1CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ OPRL1 P41146 1/20 0.32
▸ CYP11B1 P15538 4/20 0.32
▸ CYP11B2 P19099 4/20 0.32
▸ EGLN2 Q96KS0 1/20 0.31
▸ DPP4 P27487 2/20 0.31
▸ DPP8 Q6V1X1 2/20 0.31
▸ CHRNB1 P11230 1/20 0.31
▸ CHRNB2 P17787 1/20 0.31
▸ CHRNB4 P30926 1/20 0.31
▸ CHRNA3 P32297 1/20 0.31
▸ CHRNB3 Q05901 1/20 0.31
▸ RAF1 P04049 2/20 0.30
▸ MAP2K1 Q02750 2/20 0.30
▸ CNR1 P21554 1/20 0.30
▸ CNR2 P34972 1/20 0.30
▸ PTPN11 Q06124 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437381 0.95 CRHR1 (0.35) LMNAOPRL1CHRNB1CHRNB2CHRNB4
SCHEMBL17437486 0.88 SLC9A1 (0.33) CYP1A2CYP3A4ALOX15CYP11B1CYP11B2
SCHEMBL17437568 0.84 DPP4 (0.37) LMNAEGLN2DPP4DPP8CHRNB1
SCHEMBL17437523 0.81 DPP4 (0.39) CYP1A2CYP3A4LMNAEGLN2DPP4
SCHEMBL17437382 0.80 USP2 (0.36) CYP1A2CYP3A4LMNAEGLN2DPP4
SCHEMBL17437549 0.80 DPP4 (0.36) LMNADPP4DPP8
SCHEMBL17437537 0.77 CYP3A4 (0.36) CYP1A2CYP3A4CYP11B1CYP11B2
SCHEMBL17437312 0.77 KDM4E (0.34) ALOX15CYP11B1CYP11B2
SCHEMBL17437559 0.73 SIK1 (0.33) CYP1A2CYP3A4DPP4DPP8
SCHEMBL17437388 0.72 EGLN2 (0.34) CYP1A2CYP3A4CYP11B1CYP11B2EGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 CYP1A2 25/4885CYP3A4 59/4885ALOX15 3340/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 CYP1A2 25/4885CYP3A4 59/4885ALOX15 3340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback